The trade in inferior quality medicines kills innocent patients. Perhaps 15 percent of the global drug supply outside of advanced countries is counterfeit, rising in certain markets in parts of Africa and Asia to over 50 percent. But counterfeits are not the only low-quality drugs on the market.

Provision of health care in developing regions is not keeping pace with rapid economic growth.

Pleas for a greater Western commitment to tackling developing-country problems ring hollow whengovernments of poor countries maintain taxesthatensure poor people die needlessly.

Pleas for a greater Western helpring hollow when the governments of poor countries maintain taxes and bureaucracies that frustrate healthcare andcausetheir own citizens to die needlessly.

In the time it takes you to read this column, at least ten people in poor countries will die from diseases that are preventable and curable.

In the time it takes you to read this column, at least ten people in poor countries will die from diseases that are preventable and curable.

Excessive tariffs on essential medicines hurt global health.

The selective income taxexemption for home-state municipal bonds at issue in Davis v. Kentucky Department of Revenue is a barrier to interstate commerce.